# A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008

> **NCT04946903** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 33 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** RLD2007
- **DRUG:** RLD2008
- **DRUG:** HCP1902

## Key facts

- **NCT ID:** NCT04946903
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-10
- **Primary completion:** 2021-08-10
- **Final completion:** 2021-08-10
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2022-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04946903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04946903, "A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04946903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*